AU7363691A - Methods for treating interleukin-1 mediated diseases - Google Patents
Methods for treating interleukin-1 mediated diseasesInfo
- Publication number
- AU7363691A AU7363691A AU73636/91A AU7363691A AU7363691A AU 7363691 A AU7363691 A AU 7363691A AU 73636/91 A AU73636/91 A AU 73636/91A AU 7363691 A AU7363691 A AU 7363691A AU 7363691 A AU7363691 A AU 7363691A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- mediated diseases
- treating interleukin
- interleukin
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50274590A | 1990-04-02 | 1990-04-02 | |
US502745 | 1990-04-02 | ||
US52421090A | 1990-05-16 | 1990-05-16 | |
US524210 | 1990-05-16 | ||
US53055390A | 1990-05-29 | 1990-05-29 | |
US530553 | 1990-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7363691A true AU7363691A (en) | 1991-10-03 |
AU649245B2 AU649245B2 (en) | 1994-05-19 |
Family
ID=27414214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73636/91A Expired AU649245B2 (en) | 1990-04-02 | 1991-03-20 | Methods for treating interleukin-1 mediated diseases |
Country Status (5)
Country | Link |
---|---|
JP (3) | JP2609485B2 (en) |
KR (1) | KR920005691A (en) |
AU (1) | AU649245B2 (en) |
CA (1) | CA2039458A1 (en) |
IL (1) | IL97641A0 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997028828A1 (en) * | 1996-02-09 | 1997-08-14 | Amgen Boulder Inc. | Composition comprising interleukin-1 inhibitor and controlled release polymer |
US5739282A (en) * | 1994-10-13 | 1998-04-14 | Applied Research Systems Ars Holding N.V. | Interleukin-1 antagonist |
US5837495A (en) * | 1994-10-13 | 1998-11-17 | Applied Research Systems Ars Holding N.V. | DNA encoding interleukin-1 antagonist |
AU736876B2 (en) * | 1996-12-06 | 2001-08-02 | Amgen, Inc. | Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP2087908A1 (en) | 2001-06-26 | 2009-08-12 | Amgen, Inc. | Antibodies to opgl |
EP2277543A1 (en) | 2002-09-06 | 2011-01-26 | Amgen, Inc | Therapeutic anti-IL-1R1 monoclonal antibody |
WO2013170636A1 (en) | 2012-05-18 | 2013-11-21 | 爱德迪安(北京)生物技术有限公司 | Protein and protein conjugate for diabetes treatment, and applications thereof |
EP2816060A1 (en) | 2005-11-14 | 2014-12-24 | Amgen Inc. | Rankl antibody-PTH/PTHRP chimeric molecules |
WO2015191783A2 (en) | 2014-06-10 | 2015-12-17 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
WO2020035482A1 (en) | 2018-08-13 | 2020-02-20 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
ATE214939T1 (en) * | 1991-10-31 | 2002-04-15 | Univ Manchester | TREATMENT OF NEUROLOGICAL CONDITIONS BY AN INTERLEUKIN-I INHIBITING COMPOUND |
ATE270550T1 (en) * | 1995-04-07 | 2004-07-15 | Teijin Ltd | ACTIVE SUBSTANCE TO PROTECT ORGANS OR TISSUES |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
EP1712239A3 (en) * | 2000-05-12 | 2007-08-22 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
KR100733025B1 (en) * | 2006-05-24 | 2007-06-28 | 윤인석 | A structure of bottle cap with safety |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02223597A (en) * | 1988-10-24 | 1990-09-05 | Otsuka Pharmaceut Co Ltd | Interleukin-1beta derivative |
JP2863265B2 (en) * | 1989-05-19 | 1999-03-03 | ハダサ メディカル オーガニゼーション | Interleukin 1 inhibitor |
-
1991
- 1991-03-20 AU AU73636/91A patent/AU649245B2/en not_active Expired
- 1991-03-21 IL IL97641A patent/IL97641A0/en not_active IP Right Cessation
- 1991-03-28 CA CA002039458A patent/CA2039458A1/en not_active Abandoned
- 1991-04-01 JP JP3068640A patent/JP2609485B2/en not_active Expired - Lifetime
- 1991-04-02 KR KR1019910005277A patent/KR920005691A/en not_active Application Discontinuation
-
1996
- 1996-06-26 JP JP8166399A patent/JP2942196B2/en not_active Expired - Lifetime
-
1999
- 1999-01-18 JP JP11009712A patent/JPH11269089A/en active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739282A (en) * | 1994-10-13 | 1998-04-14 | Applied Research Systems Ars Holding N.V. | Interleukin-1 antagonist |
US5837495A (en) * | 1994-10-13 | 1998-11-17 | Applied Research Systems Ars Holding N.V. | DNA encoding interleukin-1 antagonist |
AU724960C (en) * | 1996-02-09 | 2002-08-15 | Swedish Orphan Biovitrum Ab (Publ) | Composition comprising interleukin-1 inhibitor and controlled release polymer |
AU724960B2 (en) * | 1996-02-09 | 2000-10-05 | Swedish Orphan Biovitrum Ab (Publ) | Composition comprising interleukin-1 inhibitor and controlled release polymer |
WO1997028828A1 (en) * | 1996-02-09 | 1997-08-14 | Amgen Boulder Inc. | Composition comprising interleukin-1 inhibitor and controlled release polymer |
CZ299025B6 (en) * | 1996-02-09 | 2008-04-02 | Amgen Inc. | Pharmaceutical composition and use thereof |
AU736876B2 (en) * | 1996-12-06 | 2001-08-02 | Amgen, Inc. | Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases |
US6733753B2 (en) * | 1997-02-10 | 2004-05-11 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP2087908A1 (en) | 2001-06-26 | 2009-08-12 | Amgen, Inc. | Antibodies to opgl |
EP3492100A1 (en) | 2001-06-26 | 2019-06-05 | Amgen Inc. | Antibodies to opgl |
EP2277543A1 (en) | 2002-09-06 | 2011-01-26 | Amgen, Inc | Therapeutic anti-IL-1R1 monoclonal antibody |
EP3020414A1 (en) | 2002-09-06 | 2016-05-18 | Amgen, Inc | Therapeutic anti-il-1r1 monoclonal antibody |
EP2816060A1 (en) | 2005-11-14 | 2014-12-24 | Amgen Inc. | Rankl antibody-PTH/PTHRP chimeric molecules |
WO2013170636A1 (en) | 2012-05-18 | 2013-11-21 | 爱德迪安(北京)生物技术有限公司 | Protein and protein conjugate for diabetes treatment, and applications thereof |
WO2015191783A2 (en) | 2014-06-10 | 2015-12-17 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
WO2020035482A1 (en) | 2018-08-13 | 2020-02-20 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
Also Published As
Publication number | Publication date |
---|---|
JPH11269089A (en) | 1999-10-05 |
JP2942196B2 (en) | 1999-08-30 |
CA2039458A1 (en) | 1991-10-03 |
JPH05112462A (en) | 1993-05-07 |
JPH09118632A (en) | 1997-05-06 |
JP2609485B2 (en) | 1997-05-14 |
KR920005691A (en) | 1992-04-03 |
IL97641A0 (en) | 1992-06-21 |
AU649245B2 (en) | 1994-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU616091B2 (en) | Treatment process | |
AU624464B2 (en) | Skin treatment method | |
AU7629594A (en) | Imidazoles for treating cytokine mediated disease | |
AU2293888A (en) | Dosage form for treating cardiovascular diseases | |
AU5045190A (en) | Filter apparatus | |
AU7363691A (en) | Methods for treating interleukin-1 mediated diseases | |
AU5521290A (en) | Induction-based assistive listening system | |
AU4524889A (en) | Method for the treatment of periodontal disease | |
AU5869990A (en) | Means for surgical treatment | |
AU3604989A (en) | Depilation apparatus | |
AU6596590A (en) | Deoxyfluoronucleoside process | |
AU6061090A (en) | Photocoagulation apparatus | |
AU6386390A (en) | Therapeutic necleosides | |
AU7438691A (en) | Nut harvesting apparatus | |
AU6798490A (en) | Ocular treatment apparatus | |
AU7213291A (en) | Straw treatment apparatus | |
AU5972190A (en) | Halogen-exchange process | |
AU8601791A (en) | Dewaxing process | |
AU613355B2 (en) | Method for treating skin diseases | |
AU6215290A (en) | Method for activating protein c | |
AU7467891A (en) | Process for imparting knowledge | |
AU3605089A (en) | Depilation apparatus | |
AU7294491A (en) | Labdanes and process for their preparation | |
AU9021291A (en) | Adjustable diaper | |
AU6598490A (en) | Electro-surgery apparatus |